EDCTP Call: Vaccines for diarrhoeal diseases or lower respiratory tract infections (deadline: 30th Oct 2018)
This Call for Proposals will support clinical trials that can accelerate the development of vaccines for diarrhoeal infections and lower respiratory tract infections in sub-Saharan Africa.
Objectives
Projects funded under this Call for Proposals should:
contribute to the achievement of SDG3 ‘Ensure healthy lives and promote well-being for all at all ages’
- contribute towards the reduction of the burden of diarrhoeal diseases or lower respiratory tract infections in sub-Saharan Africa
- lead to the advancement of vaccine candidates along the product development pipeline.
Proposals should include one or more clinical trials (phase I to III) in sub-Saharan Africa for vaccine candidates towards one or more of the following pathogens:
- Diarrhoeal diseases: Shigella and/or enterotoxigenic E. coli (ETEC)
- Lower respiratory tract infections: Respiratory Syncytial Virus (RSV) or Group B streptococcus (GBS).
Proposals should describe the target product profiles; particularly indication, target populations, safety and/or efficacy, and describe how the candidates contribute to the global product development pipeline for the disease.
Eligibility
Consortia comprising a minimum of three independent legal entities are eligible to apply. Two of the legal entities shall be established in two different European Partner States and one of the legal entities must be established in a sub-Saharan African country.
Level of funding
2-4 grants between EUR 5 and 10 million eachare expected to share a call budget of €23 million for a project duration of 36-60 months.
For further details please visit the funder's website.